ArticleClinical and translational medicine2022

RNASeq profiling of COVID19-infected patients identified an EIF2AK2 inhibitor as a potent SARS-CoV-2 antiviral.

Sidharth Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.